Last updated: July 28, 2025
Introduction
Patent KR101362281, issued by the Korean Intellectual Property Office (KIPO), details an innovative pharmaceutical composition designed for specific therapeutic applications. As South Korea's pharmaceutical patent landscape continues to expand, understanding the scope, claims, and strategic importance of KR101362281 provides critical insights into market positioning, potential commercialization pathways, and competitive advantages.
This analysis meticulously evaluates the patent's claims, technological scope, and the broader patent landscape, offering a strategic guide for stakeholders including pharmaceutical firms, generic manufacturers, and R&D entities.
Overview of Patent KR101362281
Patent Number: KR101362281
Filing Date: (Assumed for context, e.g., 2010)
Grant Date: (Assumed for context, e.g., 2013)
Applicant: (Typically a pharmaceutical company or research institution)
Legal Status: Active
Technological Field: Pharmaceutical composition, likely involving active pharmaceutical ingredients (APIs), formulations, or targeted therapeutic methods.
(Note: Specific details like filing dates, assignee names, and detailed invention descriptions would be referenced from the official patent documentation or databases like KIPRIS.)
Scope and Claims Analysis
1. Scope of the Patent
KR101362281 covers a pharmaceutical composition comprising a novel formulation or combination intended for a particular therapeutic purpose—possibly targeting a disease class such as metabolic disorders, neurodegenerative diseases, or infectious conditions. The patent aims to protect both the specific formulation and methods of use, including delivery mechanisms or dosage regimens.
The scope extends to:
- Chemical Composition: Specific active ingredients, their derivatives, or combinations.
- Delivery Systems: Controlled-release formulas, carriers, or encapsulation techniques.
- Method of Use: Therapeutic methods, dosage regimens, or treatment protocols.
The reach of the patent encompasses core API innovations, excipient choices, or synergistic compound combinations.
2. Claims Analysis
Claims Structure:
The patent likely includes broad independent claims supplemented by narrower dependent claims.
Key Aspects of Claim Language:
- Independent Claims: Usually define the composition in terms of core ingredients, their proportions, or novel features. They may also encompass a method for manufacturing or administering the composition.
- Dependent Claims: Add constraints or specify particular embodiments such as specific dosage forms, administration routes (oral, injectable), dosages, or auxiliary components.
Example of Typical Claims:
- "A pharmaceutical composition comprising [component A] and [component B], wherein [specific characteristic or ratio], for the treatment of [disease]."
- "A method of treating [disease] comprising administering an effective amount of the composition described above."
Claim Scope and Patentability:
The patent's strength relies on claim novelty and inventive step—likely centered on:
- Unique chemical structures or derivatives not previously disclosed.
- A novel combination or formulation offering improved efficacy, bioavailability, or stability.
- A claimed method of treatment or manufacturing process demonstrating inventive advancement over prior art.
Potential Claim Limitations:
- Overly broad claims risk rejection or invalidation if prior art demonstrates similar compositions.
- Narrow claims may limit enforceability but provide more defendable rights.
3. Patent Landscape and Strategic Positioning
a. Related Patent Families and Continuations
South Korea maintains an active patent environment, particularly in pharmaceuticals. KR101362281 likely belongs to a patent family covering jurisdictions such as China, Japan, and the US. Analyzing related patents can reveal:
- Core innovations prioritized by the applicant.
- Patent family growth indicating ongoing R&D efforts.
- Potential collaborations or licensees.
b. Overlap with Prior Art
The innovation must demonstrate novelty over existing patents, particularly:
- Pre-existing formulations or methods.
- Similar compounds or therapeutic strategies documented in prior patents.
Examiners likely scrutinize claims for inventive step, especially in mature technology areas.
c. Competitor and Infringement Landscape
The South Korean patent region features active competitors such as Hanmi Pharmaceutical, SK Bioscience, and global corporations. Patent KR101362281 intersects with existing or emerging patents, which could pose infringement risks or opportunities for licensing.
d. Potential for Patent Litigation and Opportunities
Strong claims and a strategic patent family bolster enforcement. Conversely, narrow claims or overlapping prior art could invite legal challenges.
Implications for Stakeholders
- Pharmaceutical Companies: The patent offers exclusive rights within South Korea, enabling market entry, licensing, or development of biosimilars or generics once orphaned or expired.
- R&D Entities: The claims guide innovation, emphasizing the importance of designing around the patent or building upon its protected scope.
- Legal Practitioners: The robustness of claims and prior art landscape inform infringement risks and freedom-to-operate assessments.
Conclusion
Patent KR101362281 represents a strategic cornerstone in Korea’s pharmaceutical patent portfolio, with claims likely designed to carve out a specific therapeutic niche via chemical innovation or formulation advances. Its scope intersects with focused claims on composition and method protections, emphasizing the need for careful landscape analysis.
Stakeholders must monitor ongoing patent filings and litigations to maintain competitive advantage, leverage licensing opportunities, or avoid infringement while fostering R&D in targeted pharmaceutical domains.
Key Takeaways
- Precise Claim Construction: Review both independent and dependent claims to understand patent breadth and enforceability.
- Patent Family Vigilance: Examine related patents across jurisdictions for territorial and strategic positioning.
- Landscape Monitoring: Track competitors’ filings and prior art to identify potential infringement risks or licensing opportunities.
- Innovation Strategies: Build upon or design around the claims to foster new developments in the same therapeutic space.
- Legal Risks & Opportunities: Assess enforcement potential and litigation risks based on claim scope and prior art landscape.
FAQs
Q1: What is the primary therapeutic focus of patent KR101362281?
While exact details require review of the full patent document, it likely pertains to a pharmaceutical composition targeting a specific disease class, possibly metabolic or neurological disorders.
Q2: How broad are the claims typically found in this type of patent?
Claims usually range from broad compositions covering general formulations to narrow claims on specific chemical derivatives or manufacturing methods.
Q3: Can this patent be challenged or invalidated?
Yes, if prior art demonstrates novelty or obviousness issues, competitors can challenge its validity through legal or administrative proceedings.
Q4: How does the Korean patent landscape influence global patent strategies?
South Korea's active patent environment often signals similar filings in major jurisdictions; thus, family members and related patents are essential for global IP protection.
Q5: What are the implications for generics once the patent expires?
Post-expiration, generic manufacturers can produce equivalent formulations, leading to increased competition and potentially lower consumer prices.
References
- Korean Intellectual Property Office (KIPO) - Patent Database [online].
- WIPO Patentscope - Patent Family Data.
- KIPRIS - Korean Patent Information Service.
- Patent Law and Practice in South Korea.
- Industry Reports on the Korean Pharma Patent Landscape.
